vs
Side-by-side financial comparison of Four Corners Property Trust, Inc. (FCPT) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
Four Corners Property Trust, Inc. is the larger business by last-quarter revenue ($78.2M vs $57.3M, roughly 1.4× RHYTHM PHARMACEUTICALS, INC.). Four Corners Property Trust, Inc. runs the higher net margin — 38.8% vs -83.0%, a 121.8% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 9.4%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 8.4%).
Four Corners Property Trust, Inc. is a publicly traded real estate investment trust that acquires, owns, and manages a portfolio of high-quality net-leased commercial properties. Its assets are primarily restaurant and retail locations across the United States, with tenants largely operating in stable consumer-facing industry segments with proven operational performance.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
FCPT vs RYTM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $78.2M | $57.3M |
| Net Profit | $30.4M | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | 55.3% | -82.2% |
| Net Margin | 38.8% | -83.0% |
| Revenue YoY | 9.4% | 36.9% |
| Net Profit YoY | 16.0% | -9.6% |
| EPS (diluted) | $0.28 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $78.2M | — | ||
| Q4 25 | $75.7M | $57.3M | ||
| Q3 25 | $74.1M | $51.3M | ||
| Q2 25 | $72.8M | $48.5M | ||
| Q1 25 | $71.5M | $32.7M | ||
| Q4 24 | $68.3M | $41.8M | ||
| Q3 24 | $66.8M | $33.3M | ||
| Q2 24 | $66.5M | $29.1M |
| Q1 26 | $30.4M | — | ||
| Q4 25 | $29.4M | $-47.5M | ||
| Q3 25 | $28.8M | $-52.9M | ||
| Q2 25 | $27.9M | $-46.6M | ||
| Q1 25 | $26.2M | $-49.5M | ||
| Q4 24 | $26.2M | $-43.3M | ||
| Q3 24 | $25.6M | $-43.6M | ||
| Q2 24 | $24.7M | $-32.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% |
| Q1 26 | 55.3% | — | ||
| Q4 25 | — | -82.2% | ||
| Q3 25 | — | -102.6% | ||
| Q2 25 | — | -93.4% | ||
| Q1 25 | — | -143.7% | ||
| Q4 24 | — | -98.6% | ||
| Q3 24 | — | -132.0% | ||
| Q2 24 | — | -139.2% |
| Q1 26 | 38.8% | — | ||
| Q4 25 | 38.9% | -83.0% | ||
| Q3 25 | 38.9% | -103.1% | ||
| Q2 25 | 38.3% | -96.1% | ||
| Q1 25 | 36.6% | -151.4% | ||
| Q4 24 | 38.3% | -103.6% | ||
| Q3 24 | 38.3% | -131.2% | ||
| Q2 24 | 37.1% | -110.9% |
| Q1 26 | $0.28 | — | ||
| Q4 25 | $0.27 | $-0.73 | ||
| Q3 25 | $0.28 | $-0.82 | ||
| Q2 25 | $0.28 | $-0.75 | ||
| Q1 25 | $0.26 | $-0.81 | ||
| Q4 24 | $0.27 | $-0.71 | ||
| Q3 24 | $0.27 | $-0.73 | ||
| Q2 24 | $0.27 | $-0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $29.6M | $388.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.7B | $139.1M |
| Total Assets | $3.0B | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $29.6M | — | ||
| Q4 25 | $12.1M | $388.9M | ||
| Q3 25 | $6.7M | $416.1M | ||
| Q2 25 | $6.0M | $291.0M | ||
| Q1 25 | $22.3M | $314.5M | ||
| Q4 24 | $4.1M | $320.6M | ||
| Q3 24 | $44.5M | $298.4M | ||
| Q2 24 | $17.2M | $319.1M |
| Q1 26 | — | — | ||
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.2B | — |
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.6B | $139.1M | ||
| Q3 25 | $1.5B | $148.8M | ||
| Q2 25 | $1.5B | $-11.9M | ||
| Q1 25 | $1.4B | $18.9M | ||
| Q4 24 | $1.5B | $21.7M | ||
| Q3 24 | $1.4B | $11.2M | ||
| Q2 24 | $1.3B | $39.3M |
| Q1 26 | $3.0B | — | ||
| Q4 25 | $2.9B | $480.2M | ||
| Q3 25 | $2.8B | $506.9M | ||
| Q2 25 | $2.8B | $372.7M | ||
| Q1 25 | $2.7B | $386.7M | ||
| Q4 24 | $2.7B | $392.3M | ||
| Q3 24 | $2.6B | $363.6M | ||
| Q2 24 | $2.5B | $381.8M |
| Q1 26 | — | — | ||
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.79× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.84× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | 0.84× | — | ||
| Q2 24 | 0.92× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-25.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $192.3M | $-25.4M | ||
| Q3 25 | $48.9M | $-26.6M | ||
| Q2 25 | $43.8M | $-23.3M | ||
| Q1 25 | $51.6M | $-40.4M | ||
| Q4 24 | $144.1M | $-18.8M | ||
| Q3 24 | $43.4M | $-25.2M | ||
| Q2 24 | $39.7M | $-29.1M |
| Q1 26 | — | — | ||
| Q4 25 | 6.53× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.57× | — | ||
| Q1 25 | 1.97× | — | ||
| Q4 24 | 5.51× | — | ||
| Q3 24 | 1.70× | — | ||
| Q2 24 | 1.61× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FCPT
| Rental revenue | $69.8M | 89% |
| Restaurant revenue | $8.4M | 11% |
RYTM
Segment breakdown not available.
